Leap Investments’s Sabra Healthcare REIT SBRA Stock Holding History

Leap Investments’s Portfolio SBRA Stock Details SBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-47,592	Closed	-$1.02M	–	535
2019 Q4	$1.02M	Buy	+47,592	New	+$1.07M	0.48%	55

Other funds holding SBRA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LPC

Long Pond Capital New York $1.05B AUM 16.49% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Leap Investments's SBRA Position: Q1 2020 in Review

Leap Investments sold out of Sabra Healthcare REIT (SBRA) in Q1 2020, closing a stake of 47,592 shares — an estimated $1.02M sold.

Leap Investments first reported a position in SBRA in Q4 2019 and held it in 1 quarter. The position peaked at $1.02M in Q4 2019. 324 funds tracked by Wall St. Rank hold SBRA as of Q1 2020.

Leap Investments reported no remaining Sabra Healthcare REIT position as of Q1 2020 after selling out during the quarter.
Leap Investments sold 47,592 Sabra Healthcare REIT shares in Q1 2020, an estimated $1.02M.
Leap Investments first reported a position in Sabra Healthcare REIT in Q4 2019 and held it in 1 quarter.
Leap Investments's Sabra Healthcare REIT position peaked at $1.02M in Q4 2019.
324 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2020.

Based on Leap Investments's 13F filing for Q1 2020, filed 15 May 2020.